Updated Review: Improved Glycemic Control with Repaglinide-Metformin in Fixed Combination for Patients with Type 2 Diabetes

As the prevalence of type 2 diabetes continues to rise, new drug therapies will need to be explored to prevent morbidity and mortality associated with diabetes as well as growing health care costs. Type 2 diabetes is characterized by decreased insulin secretion and sensitivity. Numerous oral medicat...

Descripción completa

Detalles Bibliográficos
Autores principales: Richard, John W., Raskin, Philip
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Libertas Academica 2011
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3411545/
https://www.ncbi.nlm.nih.gov/pubmed/22879792
http://dx.doi.org/10.4137/CMED.S5094

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3411545/
https://www.ncbi.nlm.nih.gov/pubmed/22879792
http://dx.doi.org/10.4137/CMED.S5094

Ejemplares similares